GL1X · GenesisL1 explorer

Research workbench

Crystal structure of an anti-SARS-cov-2 human neutralizing antibody Fab fragment, C110

Analyse Crystal structure of an anti-SARS-cov-2 human neutralizing antibody Fab… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7K8P
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C110 Fab heavy chain; C110 Fab light chain
Pockets
2 · best druggability 0.52

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HC110 Fab heavy chainprotein2168% helix, 51% strand—
LC110 Fab light chainprotein2106% helix, 52% strand—

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13030.520.7447empty
2540.460.8521empty

Interfaces

1 interface between chains.

  • H–L · 1693 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 7K8P · Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C110 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.